Dexmedetomidine decreases cerebral hyperperfusion incidence following carotid stenting: A double-blind, randomized controlled trial
Open Access
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Natural Science Foundation of China
- Henan Province Natural Science Foundation
This publication has 31 references indexed in Scilit:
- Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating α2-adrenoceptor: A combined randomised animal and in vitro studyBiomedicine & Pharmacotherapy, 2024
- Fisetin provides neuroprotection in pentylenetetrazole-induced cognition impairment by upregulating CREB/BDNFEuropean Journal of Pharmacology, 2023
- The role of the vagus nerve on dexmedetomidine promoting survival and lung protection in a sepsis model in ratsEuropean Journal of Pharmacology, 2022
- Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysisBritish Journal of Anaesthesia, 2019
- Transcranial Doppler 24 Hours after Carotid Endarterectomy Accurately Identifies Patients Not at Risk of Cerebral Hyperperfusion SyndromeEuropean Journal of Vascular and Endovascular Surgery, 2019
- Clinical Predictors of Hyperperfusion Syndrome Following Carotid Stenting: Results From a National Prospective Multicenter StudyJACC: Cardiovascular Interventions, 2019
- Cerebral Metabolic Changes During SleepCurrent Neurology and Neuroscience Reports, 2018
- Cerebral hyperperfusion syndrome and intracranial hemorrhage after carotid endarterectomy or carotid stenting: A meta-analysisJournal of the Neurological Sciences, 2017
- Incidence, predictors, and outcomes of hemodynamic instability following carotid angioplasty and stentingJournal of Vascular Surgery, 2013
- Prediction of Cerebral Hyperperfusion after Carotid Endarterectomy with Transcranial DopplerEuropean Journal of Vascular and Endovascular Surgery, 2012